Kronox Lab Sciences Announces Q1 Results for FY2025; Updates Auditors and AGM Details
Kronox Lab Sciences Limited, during its Board of Directors meeting held on August 12, 2026, announced the Unaudited Standalone Financial Results for the quarter ended June 30, 2025. The company also approved key corporate decisions related to its upcoming Annual General Meeting (AGM) and appointed specialized auditors for the fiscal year 2026-27.The Board meeting addressed several operational updates, including the appointment of new Cost Auditors and the ratification of existing internal audit services.
Financial Performance Overview
The Unaudited Standalone Financial Results were reviewed by independent statutory auditors and approved by the Board of Directors on August 12, 2026. The results are presented in Lakhs of Rupees (Rs).| Item | Q Ended 31.03.2025 (Unaudited) | Q Ended 30.06.2025 (Unaudited) | Q Ended 30.06.2025 (Audited) | Year Ended 31.03.2026 (Audited) |
|---|---|---|---|---|
| INCOME FROM OPERATION | ||||
| Revenue from Operation | 28,305 | 26,126 | 24,673 | - |
| Other Income | 1,297 | 246 | 873 | 5,194 |
| Total Income | 2,968.3 | 2,827.3 | 2,516.0 | 10,641.4 |
| EXPENSES | ||||
| Cost of Materials Consumed | 15,093 | 11,343 | - | - |
| Changes in Inventories | (11.4) | 362 | (111.7) | (562) |
| Employee Benefits Expenses | 1,933 | 1,640 | 1,784 | 7,403 |
| Finance Costs | 33 | 34 | 0 | 114 |
| Depreciation and Amortisation Expenses | 452 | 59 | 40.1 | 2,048 |
| Other Expenses | 347.6 | 326.2 | 2775 | 1,297 |
| TOTAL EXPENSES | 1,987.3 | 1,730.2 | 1,671.9 | 6,911.1 |
| Profit before Tax | 981.0 | 1,097.1 | 844.1 | 3,730.3 |
| Tax Expenses | 2,530 | 2,965 | 2,184 | 9,720 |
| Profit for the Period (post-tax) | 7303 | 8002 | 5273 | 27,660 |
| Total Comprehensive Income for the Period | 727.3 | 808.2 | 630.3 | 2,787.7 |
| Paid up Share Capital | 37,104 | 37,411 | 37,104 | 37,902 |
| Other Equity Earnings per equity share (Rs.) | - | 22 | 7 | 7.5 |
Corporate Actions and AGM Details
The Board meeting focused on finalizing corporate governance matters as well as planning for the Annual General Meeting (AGM).Key Decisions:
- Annual General Meeting (AGM): The AGM is scheduled to be held on September 16, 2026.
- Record Date and Book Closure: To determine the entitlement of members concerning the final dividend (if declared at the AGM), the company will observe a book closure period for Equity Shares from Thursday, September 10, 2026, to Wednesday, September 16, 2026. The Record Date has been set as September 9, 2026.
- Auditor Appointments: M/s Jaimin & Associates was re-appointed as the Internal Auditor for the fiscal year 2026-27 (Term: One year). Furthermore, M/s Diwanji & Associates, Cost Accountants, was appointed as the Cost Auditors for the financial year 2026-27 (Term: One year).
Independent Review Report Highlights
A review report concerning the quarterly unaudited standalone financial results was conducted by Mahesh Udhwani & Associates. The review confirmed that nothing came to their attention which suggested that the accompanying statement of unaudited financial results, prepared in accordance with Indian Accounting Standards (IND AS), contained any material misstatement or failed to disclose required information.The company operates only one reporting segment under Ind As-108: manufacturing of High Purity Specialty Fine Chemical.
KRONOX Stock Price Movement
On Wednesday, Kronox Lab Sciences Limited shares surged after the close, settling at ₹173.93 after gaining 3.72%. The stock traded within a range between ₹167.3 and ₹178.73, maintaining a strong hold on its 52-week high territory.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.